AG Leiter: Assoc. Prof. PD Dr. Martin Bodingbauer
AG Leiter: Medizinische Universität Wien
Universitätsklinik für Chirurgie
Währinger Gürtel 18-20
1090 Wien
Tel: +43-1-40400-56210
Fax: +43-1-40400-56410
Email: martin.bodingbauer@meduniwien.ac.at
Stellvertreter:
OA Dr. Helwig Wundsam
helwig.wundsam@Âordensklinikum.at
Aktuelles aus der Arbeitsgruppe
Literaturhinweise
7. 01.2020- Prognostic role of preoperative albumin-bilirubin grade on patients with hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis.
- Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
- Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer.
- Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis.
- Laparoscopic versus open limited liver resection for hepatocellular carcinoma with liver cirrhosis: a propensity score matching study with the Hiroshima Surgical study group of Clinical Oncology (HiSCO).
- Long term recurrence free survival in a stage IV gallbladder cancer treated with chemotherapy plus trastuzumab and salvage liver resection.
- Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma.
- Repeat liver resection versus salvage liver transplant for recurrent hepatocellular carcinoma: A propensity score-adjusted and -matched comparison analysis.
- Intraoperative radiofrequency ablation and distilled water peritoneal lavage for spontaneously ruptured hepatocellular carcinoma.
- Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1).
- Cholecystitis and risk of pancreatic, liver, and biliary tract cancer in patients undergoing cholecystectomy.
Literaturhinweise
3. 12.2019- Ischemic Cholangiopathy Following Transcatheter Arterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy: an Underestimated and Devastating Complication.
- Long-Term and Oncologic Outcomes of Robotic Versus Laparoscopic Liver Resection for Metastatic Colorectal Cancer: A Multicenter, Propensity Score Matching Analysis.
- Hepatic resection after neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer: need for cautious planning.
- Histological tumor response assessment in colorectal liver metastases after neoadjuvant chemotherapy: impact of the variation in tumor regression grading and peritumoral lymphocytic infiltration.
- Liver microwave ablation: a systematic review of various FDA-approved systems.
- Liver Resection Is Justified in Patients with BCLC Intermediate Stage Hepatocellular Carcinoma without Microvascular Invasion.
- Locoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future Directions.
- Robotic hepatic surgery in malignancy: review of the current literature.
- Hamartomas and malformations of the liver.
Literaturhinweise
8. 11.2019- Laparoscopic liver resection for liver tumours in proximity to major vasculature: A single-center comparative study.
- Resection of intrahepatic cholangiocarcinoma in elderly patients – is it reasonable?
- Total laparoscopic versus open radical resection for hilar cholangiocarcinoma.
- Shrinkage of hepatocellular carcinoma after radiofrequency ablation following transcatheter arterial chemoembolization: Analysis of contributing factors.